David Griffin 🦠🧫💉
@drdavidwjg.bsky.social
👨🏼🎓BSc, MBBS, MPH, FRACP👨🏼⚕️
Infectious Diseases Doc, PhD Candidate. Interests: #HIV, #BBV, #TxID, #IPC, #Vaccines
#IDSky #HIVSky
Auch auf Deutsch verfügbar.
🇦🇺🇩🇪🏳️🌈 he/him
Infectious Diseases Doc, PhD Candidate. Interests: #HIV, #BBV, #TxID, #IPC, #Vaccines
#IDSky #HIVSky
Auch auf Deutsch verfügbar.
🇦🇺🇩🇪🏳️🌈 he/him
Pleased to share results of our discrete choice experiment of the influence of HIV on organ procurement and allocation in Australia #HIVAIDS2025
#healthequity #IDsky #HIVsky #TxIDsky #PhD
#healthequity #IDsky #HIVsky #TxIDsky #PhD
September 15, 2025 at 5:03 AM
Pleased to share results of our discrete choice experiment of the influence of HIV on organ procurement and allocation in Australia #HIVAIDS2025
#healthequity #IDsky #HIVsky #TxIDsky #PhD
#healthequity #IDsky #HIVsky #TxIDsky #PhD
🚨Review just out in @hivmedicine.bsky.social 🚨
“Solid organ transplantation in people with #HIV: Outcomes, obstacles and opportunities”
#IDSky #HIVSky #TxIDSky
ft. David Ruschena, Prof. James McMahon, Prof. Jenny Hoy
doi.org/10.1111/hiv....
“Solid organ transplantation in people with #HIV: Outcomes, obstacles and opportunities”
#IDSky #HIVSky #TxIDSky
ft. David Ruschena, Prof. James McMahon, Prof. Jenny Hoy
doi.org/10.1111/hiv....
Solid organ transplantation in people with HIV: Outcomes, obstacles and opportunities
Objective People with HIV experience disparate access to solid organ transplantation (SOT), despite mounting evidence for comparable outcomes. This review aims to understand the outcomes following S...
doi.org
August 15, 2025 at 9:32 PM
🚨Review just out in @hivmedicine.bsky.social 🚨
“Solid organ transplantation in people with #HIV: Outcomes, obstacles and opportunities”
#IDSky #HIVSky #TxIDSky
ft. David Ruschena, Prof. James McMahon, Prof. Jenny Hoy
doi.org/10.1111/hiv....
“Solid organ transplantation in people with #HIV: Outcomes, obstacles and opportunities”
#IDSky #HIVSky #TxIDSky
ft. David Ruschena, Prof. James McMahon, Prof. Jenny Hoy
doi.org/10.1111/hiv....
Important #latebreaker study at #CROI2025 SCORPIO-PEP phase III RCT showed ensitrelvir (Day 1: 375mg, Day 2-5: 125mg) reduced PCR positive, symptomatic #COVID19 in HHC if started w/in 72 hrs of index case symptomatic C19 by 67%. Including in those with high risk progression. Need ICH and RACF data!
March 12, 2025 at 7:31 PM
Important #latebreaker study at #CROI2025 SCORPIO-PEP phase III RCT showed ensitrelvir (Day 1: 375mg, Day 2-5: 125mg) reduced PCR positive, symptomatic #COVID19 in HHC if started w/in 72 hrs of index case symptomatic C19 by 67%. Including in those with high risk progression. Need ICH and RACF data!
#CROI2025
Published today:
#Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study www.thelancet.com/journals/lan...
Great to see truly “long acting” therapies for HIV and PrEP emerging. the bar for #HIV #vaccines is ever higher!
Published today:
#Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study www.thelancet.com/journals/lan...
Great to see truly “long acting” therapies for HIV and PrEP emerging. the bar for #HIV #vaccines is ever higher!
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
Following administration of once-yearly intramuscular lenacapavir, median plasma concentrations
exceeded those associated with efficacy in phase 3 studies of twice-yearly subcutaneous
lenacapavir for ...
www.thelancet.com
March 11, 2025 at 11:24 PM
#CROI2025
Published today:
#Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study www.thelancet.com/journals/lan...
Great to see truly “long acting” therapies for HIV and PrEP emerging. the bar for #HIV #vaccines is ever higher!
Published today:
#Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study www.thelancet.com/journals/lan...
Great to see truly “long acting” therapies for HIV and PrEP emerging. the bar for #HIV #vaccines is ever higher!
Reposted by David Griffin 🦠🧫💉
Calling Our Patients “High Risk” Hurts Them
"Being called risky or associated w risk b/c of your sexual health decisions makes most people feel ashamed. And that shame is nothing more than another barrier to care. "
A banger op-ed by @jncherabiemd.bsky.social
www.thebodypro.com/hiv/calling-...
"Being called risky or associated w risk b/c of your sexual health decisions makes most people feel ashamed. And that shame is nothing more than another barrier to care. "
A banger op-ed by @jncherabiemd.bsky.social
www.thebodypro.com/hiv/calling-...
www.thebodypro.com
December 10, 2024 at 6:10 PM
Calling Our Patients “High Risk” Hurts Them
"Being called risky or associated w risk b/c of your sexual health decisions makes most people feel ashamed. And that shame is nothing more than another barrier to care. "
A banger op-ed by @jncherabiemd.bsky.social
www.thebodypro.com/hiv/calling-...
"Being called risky or associated w risk b/c of your sexual health decisions makes most people feel ashamed. And that shame is nothing more than another barrier to care. "
A banger op-ed by @jncherabiemd.bsky.social
www.thebodypro.com/hiv/calling-...
Reposted by David Griffin 🦠🧫💉
Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination.
ja.ma/4i9ghPC
ja.ma/4i9ghPC
November 28, 2024 at 12:37 AM
Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination.
ja.ma/4i9ghPC
ja.ma/4i9ghPC
Ten Americas: a systematic analysis of life expectancy disparities in the USA - @thelancet.bsky.social
Somber update on the 8 Americas study; highlights growing inequities in life expectancy, impact of structural racism and disproportionate impact of #COVID19
www.thelancet.com/journals/lan...
Somber update on the 8 Americas study; highlights growing inequities in life expectancy, impact of structural racism and disproportionate impact of #COVID19
www.thelancet.com/journals/lan...
November 23, 2024 at 11:46 PM
Ten Americas: a systematic analysis of life expectancy disparities in the USA - @thelancet.bsky.social
Somber update on the 8 Americas study; highlights growing inequities in life expectancy, impact of structural racism and disproportionate impact of #COVID19
www.thelancet.com/journals/lan...
Somber update on the 8 Americas study; highlights growing inequities in life expectancy, impact of structural racism and disproportionate impact of #COVID19
www.thelancet.com/journals/lan...
Dr Eloise Williams gave an important update confirmatory testing for #HIV in Australia.
#MicroSky #HIVsky #IDsky
#HIVinFocus
- Use of accredited NAAT in diagnostics (cf monitoring) on separate sample to initial serology
- p24 Ag immunoassay (no longer available)
- (traditional) western blot
#MicroSky #HIVsky #IDsky
#HIVinFocus
- Use of accredited NAAT in diagnostics (cf monitoring) on separate sample to initial serology
- p24 Ag immunoassay (no longer available)
- (traditional) western blot
November 23, 2024 at 11:21 PM
Dr Eloise Williams gave an important update confirmatory testing for #HIV in Australia.
#MicroSky #HIVsky #IDsky
#HIVinFocus
- Use of accredited NAAT in diagnostics (cf monitoring) on separate sample to initial serology
- p24 Ag immunoassay (no longer available)
- (traditional) western blot
#MicroSky #HIVsky #IDsky
#HIVinFocus
- Use of accredited NAAT in diagnostics (cf monitoring) on separate sample to initial serology
- p24 Ag immunoassay (no longer available)
- (traditional) western blot
Vikas Parwani from HIV/AIDS Legal Center shares a brief insight into immigration to Aus for #PWH.
Immigration exempt from discrimination laws that protect #PWH.
#HIV can be barrier due to perceived cost, but opportunities for ‘health waiver’ exist. HIV not the only barrier #PWH face. #HIVinFocus
Immigration exempt from discrimination laws that protect #PWH.
#HIV can be barrier due to perceived cost, but opportunities for ‘health waiver’ exist. HIV not the only barrier #PWH face. #HIVinFocus
November 23, 2024 at 2:03 AM
Vikas Parwani from HIV/AIDS Legal Center shares a brief insight into immigration to Aus for #PWH.
Immigration exempt from discrimination laws that protect #PWH.
#HIV can be barrier due to perceived cost, but opportunities for ‘health waiver’ exist. HIV not the only barrier #PWH face. #HIVinFocus
Immigration exempt from discrimination laws that protect #PWH.
#HIV can be barrier due to perceived cost, but opportunities for ‘health waiver’ exist. HIV not the only barrier #PWH face. #HIVinFocus
A/Prof Janine Trevillyan from #AustinHealth describes the challenges of applying the #REPRIEVEstudy in Australia; we don’t have pitavastatin and use different risk calculators. #IDsky #HIVsky
Atorva- and rosuvastatin reduce surrogates of CVD risk, though choosing ideal biomarker can be challenging.
Atorva- and rosuvastatin reduce surrogates of CVD risk, though choosing ideal biomarker can be challenging.
November 22, 2024 at 11:34 PM
A/Prof Janine Trevillyan from #AustinHealth describes the challenges of applying the #REPRIEVEstudy in Australia; we don’t have pitavastatin and use different risk calculators. #IDsky #HIVsky
Atorva- and rosuvastatin reduce surrogates of CVD risk, though choosing ideal biomarker can be challenging.
Atorva- and rosuvastatin reduce surrogates of CVD risk, though choosing ideal biomarker can be challenging.
Day 2 #HIVinFocus
Prof. Currier from #UCLA offering insights into CVD risk in #PWH.
First, association between clonal hematopoiesis and #CVD risk in #HIV demonstrated in several cohorts.
Prof. Currier from #UCLA offering insights into CVD risk in #PWH.
First, association between clonal hematopoiesis and #CVD risk in #HIV demonstrated in several cohorts.
November 22, 2024 at 10:47 PM
Day 2 #HIVinFocus
Prof. Currier from #UCLA offering insights into CVD risk in #PWH.
First, association between clonal hematopoiesis and #CVD risk in #HIV demonstrated in several cohorts.
Prof. Currier from #UCLA offering insights into CVD risk in #PWH.
First, association between clonal hematopoiesis and #CVD risk in #HIV demonstrated in several cohorts.
#HIVsky #IDsky
Remember cystatin C as an alternative to creatinine for estimating renal function in people with HIV with elevated creatinine on INSTI and/or cobicistat.
- nephrologist, Dr Nichita GAVRILESCU #HIVinFocus
Remember cystatin C as an alternative to creatinine for estimating renal function in people with HIV with elevated creatinine on INSTI and/or cobicistat.
- nephrologist, Dr Nichita GAVRILESCU #HIVinFocus
November 22, 2024 at 8:05 AM
#HIVsky #IDsky
Remember cystatin C as an alternative to creatinine for estimating renal function in people with HIV with elevated creatinine on INSTI and/or cobicistat.
- nephrologist, Dr Nichita GAVRILESCU #HIVinFocus
Remember cystatin C as an alternative to creatinine for estimating renal function in people with HIV with elevated creatinine on INSTI and/or cobicistat.
- nephrologist, Dr Nichita GAVRILESCU #HIVinFocus
Great talk by Endocrinologist A/Prof. Priya Sumithran at #HIVinFocus symposium.
- weight loss is an uphill battle
- pharmacological management available with additional health benefits
- questions remain about functional impact of muscle loss
- meds only work while taking them!
#IDsky #HIVsky
- weight loss is an uphill battle
- pharmacological management available with additional health benefits
- questions remain about functional impact of muscle loss
- meds only work while taking them!
#IDsky #HIVsky
November 22, 2024 at 1:01 AM
Great talk by Endocrinologist A/Prof. Priya Sumithran at #HIVinFocus symposium.
- weight loss is an uphill battle
- pharmacological management available with additional health benefits
- questions remain about functional impact of muscle loss
- meds only work while taking them!
#IDsky #HIVsky
- weight loss is an uphill battle
- pharmacological management available with additional health benefits
- questions remain about functional impact of muscle loss
- meds only work while taking them!
#IDsky #HIVsky
November 22, 2024 at 12:26 AM
Reposted by David Griffin 🦠🧫💉
Lower-cost versions of the #HIV prevention drug lenacapavir to be made available in 120 low- & middle-income countries.
#IDSky #GlobalHealth #PublicHealth #PrEP
www.theguardian.com/global-devel...
#IDSky #GlobalHealth #PublicHealth #PrEP
www.theguardian.com/global-devel...
‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries
Gilead Sciences announces deal to manufacture generic versions of lenacapavir, but critics say it excludes many countries where incidence is highest
www.theguardian.com
November 20, 2024 at 12:09 AM
Lower-cost versions of the #HIV prevention drug lenacapavir to be made available in 120 low- & middle-income countries.
#IDSky #GlobalHealth #PublicHealth #PrEP
www.theguardian.com/global-devel...
#IDSky #GlobalHealth #PublicHealth #PrEP
www.theguardian.com/global-devel...
One can try to slice the data however they will, but the ⬇️ in morbidity, mortality and incidence of several infectious diseases due to #vaccination is irrefutable.
We’ve seen time and again, the consequences of disruption of immunisation programs (e.g. MMR in Samoa), and ⬇️ in herd immunity #IDsky
We’ve seen time and again, the consequences of disruption of immunisation programs (e.g. MMR in Samoa), and ⬇️ in herd immunity #IDsky
November 18, 2024 at 11:28 PM
One can try to slice the data however they will, but the ⬇️ in morbidity, mortality and incidence of several infectious diseases due to #vaccination is irrefutable.
We’ve seen time and again, the consequences of disruption of immunisation programs (e.g. MMR in Samoa), and ⬇️ in herd immunity #IDsky
We’ve seen time and again, the consequences of disruption of immunisation programs (e.g. MMR in Samoa), and ⬇️ in herd immunity #IDsky
Reposted by David Griffin 🦠🧫💉
Allen Yung's Golden Rules of ID. Copied over from the Other Place for @kottonnelson.bsky.social #IDSky
November 16, 2024 at 12:03 AM
Allen Yung's Golden Rules of ID. Copied over from the Other Place for @kottonnelson.bsky.social #IDSky
Great point!
We often advocate for a unifying diagnosis (Occam’s razor), but in people with immunocompromise, it’s important not to disregard Hickam’s dictum; “Patients can have as many diseases as they damn well please!”
#Medsky #IDSky #TxIDSky
We often advocate for a unifying diagnosis (Occam’s razor), but in people with immunocompromise, it’s important not to disregard Hickam’s dictum; “Patients can have as many diseases as they damn well please!”
#Medsky #IDSky #TxIDSky
Lessons from practice for immunocompromised hosts by Dr Ai Li Yeo and A/Prof Claire Dendle
#ForbesWeek #IDSky
1. There can be more than two pathologies in immunocompromised patients
#ForbesWeek #IDSky
1. There can be more than two pathologies in immunocompromised patients
November 16, 2024 at 12:21 AM
Interesting take in @nytimes.com
Most of us know that the individual and #publichealth benefits of #vaccines are irrefutable, but we must take the opportunity to communicate differently about vaccines; listen, learn, and leverage #RFKs skepticism for good.
www.nytimes.com/2024/11/15/o...
Most of us know that the individual and #publichealth benefits of #vaccines are irrefutable, but we must take the opportunity to communicate differently about vaccines; listen, learn, and leverage #RFKs skepticism for good.
www.nytimes.com/2024/11/15/o...
Opinion | Can America’s Health Survive Robert F. Kennedy Jr.?
What Kennedy gets right.
www.nytimes.com
November 15, 2024 at 11:28 PM
Interesting take in @nytimes.com
Most of us know that the individual and #publichealth benefits of #vaccines are irrefutable, but we must take the opportunity to communicate differently about vaccines; listen, learn, and leverage #RFKs skepticism for good.
www.nytimes.com/2024/11/15/o...
Most of us know that the individual and #publichealth benefits of #vaccines are irrefutable, but we must take the opportunity to communicate differently about vaccines; listen, learn, and leverage #RFKs skepticism for good.
www.nytimes.com/2024/11/15/o...
Super pleased to receive an award for our research on barriers to #SOT for people with #HIV among clinicians and consumers in Australia.
#IDSky #HIVSky #HealthEquity
#IDSky #HIVSky #HealthEquity
November 15, 2024 at 2:34 AM
Super pleased to receive an award for our research on barriers to #SOT for people with #HIV among clinicians and consumers in Australia.
#IDSky #HIVSky #HealthEquity
#IDSky #HIVSky #HealthEquity
Reposted by David Griffin 🦠🧫💉
Y’all are going to need some infectious diseases experts
#IDSky Starter Packs
IDSky 1 go.bsky.app/LnAQjdq
IDSky 2 go.bsky.app/JNfSvQT
IDSky 3 go.bsky.app/FeogT7o
IDSky 4 go.bsky.app/D1zxj4E
IDSky 5 go.bsky.app/NgGSPeF
IDSky 6 go.bsky.app/22VBL8z
#MedSky
#IDSky Starter Packs
IDSky 1 go.bsky.app/LnAQjdq
IDSky 2 go.bsky.app/JNfSvQT
IDSky 3 go.bsky.app/FeogT7o
IDSky 4 go.bsky.app/D1zxj4E
IDSky 5 go.bsky.app/NgGSPeF
IDSky 6 go.bsky.app/22VBL8z
#MedSky
a man in a lab coat says no reason in front of a wall of cards
Alt: a man in a lab coat says “no reason”
media.tenor.com
November 15, 2024 at 12:33 AM
Y’all are going to need some infectious diseases experts
#IDSky Starter Packs
IDSky 1 go.bsky.app/LnAQjdq
IDSky 2 go.bsky.app/JNfSvQT
IDSky 3 go.bsky.app/FeogT7o
IDSky 4 go.bsky.app/D1zxj4E
IDSky 5 go.bsky.app/NgGSPeF
IDSky 6 go.bsky.app/22VBL8z
#MedSky
#IDSky Starter Packs
IDSky 1 go.bsky.app/LnAQjdq
IDSky 2 go.bsky.app/JNfSvQT
IDSky 3 go.bsky.app/FeogT7o
IDSky 4 go.bsky.app/D1zxj4E
IDSky 5 go.bsky.app/NgGSPeF
IDSky 6 go.bsky.app/22VBL8z
#MedSky